| 股票 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 福泰制药 VRTX | 生物技术 | 31.8 | 6.84 | 0.0% | 0% | 86% | 22% | 8% | 27% | 3.1% | +9% | +838% | +25% | +20% | +38% | 98% | 1384 |
| argenx SE ARGX | 生物技术 | 39.4 | 7.68 | 0.0% | 0% | 89% | 20% | 0% | 16% | 1.5% | +90% | +55% | +20% | +23% | +34% | 96% | 646 |
| 阿里拉姆制药 ALNY | 生物技术 | 46.4 | 26.30 | 0.0% | 0% | 82% | 73% | 11% | 84% | 2.6% | +65% | +213% | -9% | -33% | -42% | 54% | 356 |
| Ascendis Pharma A/S ASND | 生物技术 | 20.8 | 10.63 | 0.0% | 0% | 87% | 0% | 8% | 112% | 2.3% | +124% | +32% | +29% | +27% | +32% | 96% | 177 |
| Krystal Biotech KRYS | 生物技术 | 44.9 | 7.80 | 0.0% | 0% | 94% | 19% | 8% | 9% | 2.6% | +34% | +130% | +15% | +45% | +147% | 94% | 106 |
| TG Therapeutics TGTX | 生物技术 | 20.4 | 14.19 | 0.0% | 0% | 84% | 103% | 0% | 39% | 0.2% | +87% | +1812% | +20% | +88% | +73% | 94% | 86 |
| Caris Life Sciences CAI | 生物技术 | 67.4 | 11.97 | 0.0% | 0% | 66% | 0% | 20% | 49% | 2.4% | +97% | +76% | +46% | -7% | -28% | 71% | 71 |
| Ligand Pharmaceuticals LGND | 生物技术 | 29.4 | 5.88 | 0.0% | 0% | 95% | 14% | 1% | 35% | 2.3% | +60% | +3187% | +15% | +51% | +72% | 87% | 57 |
| 阿卡迪亚 ACAD | 生物技术 | 12.6 | 3.69 | 0.0% | 0% | 92% | 40% | 2% | 22% | 3.3% | +12% | +73% | +32% | +5% | +10% | 90% | 48 |
| MeiraGTx Holdings MGTX | 生物技术 | 16.0 | 6.19 | 0.0% | 0% | 94% | -368% | 36% | 102% | 1.0% | +145% | +23% | +52% | +75% | +86% | 90% | 13 |
| Theravance Biopharma TBPH | 生物技术 | 16.4 | 3.06 | 0.0% | 0% | — | 45% | 7% | 39% | 6.1% | +67% | +288% | +4% | -9% | +23% | 81% | 9 |
点表头排序。市值单位亿美元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。